XERS 144 DEF-14A Report Nov. 13, 2025 | Alphaminr
Xeris Biopharma Holdings, Inc.

XERS 144 Report ended Nov. 13, 2025

XERIS BIOPHARMA HOLDINGS, INC.
CIK: 1867096
Filing Type: 144
Report Date: 2025-11-13
Download URL: https://www.sec.gov/Archives/edgar/data/1867096/000195004725008827/xsl144X01/primary_doc.xml
]]>
TABLE OF CONTENTS